BD to Acquire TriPath Imaging, Inc.
Advances BD's position in cancer diagnostics
12-Sep-2006 -
BD (Becton, Dickinson and Company) announced that it has signed a definitive agreement to acquire the 93.5% of the outstanding shares of TriPath Imaging which BD does not currently own, for a cash purchase price of $9.25 per share, or approximately $350 million. The acquisition is expected to be ...
BD
biomarker
biomarkers
+1